Add to ORKGHepatocellular carcinoma is a primary liver cancer.Among treatment options for hepatocellular carcinoma, Yttrium-90 radioembolization is a promising transarterial therapy.This thesis investigates potential clinical applications of radioembolization in the treatment of the hepatocellular carcinoma (techniques of radiation segmentectomy and radiation lobectomy), and adress the problematic of the response Assessment after radioembolization.Doctorat en Sciences médicales (Médecine)info:eu-repo/semantics/nonPublishe
OBJECTIVES: The aim of this prospective study was to reveal the efficacy and safety of Yttrium-90 (Y...
Recent years have seen an increase in the number of patients with malignant tumours of the liver. In...
International audienceLes carcinomes hépatocellulaires deviennent un problème de santé publique. Les...
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and affects millions ...
Hepatocellular carcinoma remains a prominent cause of cancer-related mortality globally. Transarteri...
The term radioembolization defines those procedures in which intra-arterially injected radioactive m...
Radioembolization is an established antitumoral treatment for both primary liver tumors and liver me...
The term transarteria radioembolisation includes those procedures in which intra-arterially injected...
Transarterial radioembolization (TARE) with yttrium-90 (90Y) microspheres has been widely adopted fo...
Hepatocellular carcinoma (HCC) is the second leading cause of cancer death in the world and the live...
International audienceYttrium-90 (Y90) radioembolization is an emerging strategy to treat liver mali...
In spite of substantial progress in the management of hepatocellular carcinoma (HCC), suboptimal tre...
International audienceInterventional radiology (IR) has considerably grown since the 90s and has cur...
Radioembolization is a therapy during which radioactive microspheres are administered through a micr...
Aim : Several techniques for radionuclide therapy of hepatocellular carcinoma (HCC) have been develo...
OBJECTIVES: The aim of this prospective study was to reveal the efficacy and safety of Yttrium-90 (Y...
Recent years have seen an increase in the number of patients with malignant tumours of the liver. In...
International audienceLes carcinomes hépatocellulaires deviennent un problème de santé publique. Les...
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and affects millions ...
Hepatocellular carcinoma remains a prominent cause of cancer-related mortality globally. Transarteri...
The term radioembolization defines those procedures in which intra-arterially injected radioactive m...
Radioembolization is an established antitumoral treatment for both primary liver tumors and liver me...
The term transarteria radioembolisation includes those procedures in which intra-arterially injected...
Transarterial radioembolization (TARE) with yttrium-90 (90Y) microspheres has been widely adopted fo...
Hepatocellular carcinoma (HCC) is the second leading cause of cancer death in the world and the live...
International audienceYttrium-90 (Y90) radioembolization is an emerging strategy to treat liver mali...
In spite of substantial progress in the management of hepatocellular carcinoma (HCC), suboptimal tre...
International audienceInterventional radiology (IR) has considerably grown since the 90s and has cur...
Radioembolization is a therapy during which radioactive microspheres are administered through a micr...
Aim : Several techniques for radionuclide therapy of hepatocellular carcinoma (HCC) have been develo...
OBJECTIVES: The aim of this prospective study was to reveal the efficacy and safety of Yttrium-90 (Y...
Recent years have seen an increase in the number of patients with malignant tumours of the liver. In...
International audienceLes carcinomes hépatocellulaires deviennent un problème de santé publique. Les...